Evoke Pharma Inc Business Finance Contracts & Agreements
44 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (6)
- Modification Agreements (1)
- Purchase Agreements (5)
- Share Agreements (1)
- Stock Agreements (3)
- Underwriting Agreements (7)
- Warrant Agreements (19)
- EVOKE PHARMA, INC. AMENDMENT TO SERIES C COMMON STOCK PURCHASE WARRANT (Filed With SEC on September 27, 2024)
- Form of Exercise Price Warrant Amendment (Filed With SEC on September 27, 2024)
- Form of Warrant Amendment (Filed With SEC on June 20, 2024)
- Form of Warrant Amendment (Filed With SEC on March 25, 2024)
- Form of Representative Warrant (Filed With SEC on February 14, 2024)
- Underwriting Agreement, dated February 8, 2024, by and among Evoke Pharma, Inc., Craig-Hallum Capital Group LLC and Laidlaw & Company (UK) Ltd (Filed With SEC on February 9, 2024)
- Form of Series C Warrant (Filed With SEC on January 11, 2024)
- Form of Series B Warrant (Filed With SEC on January 11, 2024)
- Form of Series A Warrant (Filed With SEC on January 11, 2024)
- Underwriting Agreement (Filed With SEC on January 11, 2024)
- Form of Common Warrant (Filed With SEC on December 15, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on December 15, 2023)
- Underwriting Agreement (Filed With SEC on December 15, 2023)
- Evoke Pharma, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (Filed With SEC on May 11, 2023)
- Underwriting Agreement, dated January 13, 2021, by and between Evoke Pharma, Inc. and Laidlaw &Company (UK) Ltd (Filed With SEC on January 14, 2021)
- Loan Agreement, dated as of January 21, 2020, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 12, 2020)
- Amendment to Asset Purchase Agreement entered into by and between Evoke Pharma, Inc. and Mallinckrodt ARD Inc. dated March 21, 2018 (Filed With SEC on May 14, 2018)
- Form of Warrant Amendment, dated March 29, 2018 (Filed With SEC on April 4, 2018)
- Form of Warrant Amendment, dated March 22, 2018 (Filed With SEC on March 23, 2018)
- 2,413,793 Shares EVOKEPHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 16, 2017)
- FORM OF AMENDMENT TO COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 16, 2016)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on August 15, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 1, 2016)
- COMMON STOCK PURCHASE WARRANT EVOKE PHARMA, INC. (Filed With SEC on August 1, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 20, 2016)
- COMMON STOCK PURCHASE WARRANT EVOKE PHARMA, INC. (Filed With SEC on July 20, 2016)
- EVOKE PHARMA, INC. CommonStock (par value $0.0001 per share) At Market Issuance Sales Agreement (Filed With SEC on April 15, 2016)
- MODIFICATION AGREEMENT (Filed With SEC on March 10, 2016)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 1, 2016)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 7, 2015)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 14, 2015)
- EVOKE PHARMA, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on May 28, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 28, 2014)
- UNDERWRITING AGREEMENT between EVOKE PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters EVOKE PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 30, 2013)
- Form of Representatives Warrant Agreement (Filed With SEC on August 16, 2013)
- UNDERWRITING AGREEMENT between EVOKE PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters EVOKE PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 16, 2013)
- ASSET PURCHASE AGREEMENT Dated as of June 1, 2007 by and among Evoke Pharma, Inc., a Delaware corporation, PURCHASER and QuestcorPharmaceuticals, Inc., a California corporation,... (Filed With SEC on July 3, 2013)
- EVOKE PHARMA, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1. PURPOSE (Filed With SEC on June 14, 2013)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on May 24, 2013)
- ASSET PURCHASE AGREEMENT Dated as of June 1, 2007 by and among Evoke Pharma, Inc., a Delaware corporation, PURCHASER and QuestcorPharmaceuticals, Inc., a California corporation,... (Filed With SEC on May 24, 2013)
